{"disease":{"id":"ornithine-transcarbamylase-deficiency","name":"ornithine transcarbamylase deficiency"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT05910151","title":"Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan","phase":"","overall_status":"UNKNOWN","enrollment_count":2250,"lead_sponsor_name":"West Kazakhstan Medical University","has_results":false},{"nct_id":"NCT04269122","title":"A Study to Assess Plasma Ammonia Time-Normalized Area Under the Curve and Rate of Ureagenesis in Healthy Adult Subjects","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false},{"nct_id":"NCT04908319","title":"Hepatic Histopathology in Urea Cycle Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT04612764","title":"Liver Disease in Urea Cycle Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":62,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT04909346","title":"Adeno-Associated Virus (AAV) Antibody Study in Subjects OTC Deficiency, GSDIa, and Wilson Disease","phase":"","overall_status":"TERMINATED","enrollment_count":51,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false},{"nct_id":"NCT04416126","title":"Safety, Tolerability and Pharmacokinetics of ARCT-810 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Arcturus Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04442347","title":"Phase 1b Study to Assess Safety, Tolerability, and Pharmacokinetics of ARCT-810 in Stable Adult Subjects With Ornithine Transcarbamylase Deficiency","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Arcturus Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02991144","title":"Safety and Dose-Finding Study of DTX301 (scAAV8OTC) in Adults With Late-Onset Ornithine Transcarbamylase (OTC) Deficiency","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":true},{"nct_id":"NCT05092685","title":"Halting Ornithine Transcarbamylase Deficiency With Recombinant AAV in ChildrEn","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT06488313","title":"A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":9,"lead_sponsor_name":"Arcturus Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05526066","title":"Study for Adolescents and Adults With Ornithine Transcarbamylase Deficiency to Evaluate Safety and Tolerability of ARCT-810","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"Arcturus Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04717453","title":"Study to Characterize Rate of Ureagenesis in Patients With Ornithine Transcarbamylase (OTC) Deficiency","phase":"","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Ultragenyx Pharmaceutical Inc","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}